Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmniTier
San Jose, California, United States
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
OmniTier provides on‑premise, AI‑based genomic analysis appliances and software (CompStor product family) for secondary and tertiary analysis of NGS and long‑read sequencing data, improving diagnostic yield for rare genetic diseases but offering research‑use‑only tools rather than clinical trials or therapeutics.[2][4][5][1]
- Therapeutic areas
- OncologyRare Diseases
- Industry
- Biomedical IT and Biomedical Data Platforms
02
Partnerships
Genomenon (integration of Mastermind evidence sources into CompStor Insight)[1]National Center for Child Health and Development (NCCHD), Japan – use of OmniTier’s variant interpretation platform for rare disease diagnostics benchmarking[1][5]Centre for Genome Diagnostics at A*STAR’s Genome Institute of Singapore (GIS) – collaboration on on‑premise analytical infrastructure for clinical NGS assays[2]
Beyond the preview
Go deeper on OmniTier.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OmniTier.